Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Pediatric Research

• Publication date

  2010-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1203/PDR.0b013e3181f1c289PMID 20639794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurology of the newborn.

  2013cited by this paper
• Mild neonatal hypoxia-ischemia induces long-term motor- and cognitive impairments in mice.

  2010cited by this paper
• Mesenchymal Stem-Cell Transplantation for Hypoxic-Ischemic Brain Injury in Neonatal Rat Model

  2010cited by this paper
• Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.

  2010cited by this paper
• The chemokine SDF‐1/CXCL12 contributes to the ‘homing’ of umbilical cord blood cells to a hypoxic‐ischemic lesion in the rat brain

  2009cited by this paper
• BDNF-Hypersecreting Human Mesenchymal Stem Cells Promote Functional Recovery, Axonal Sprouting, and Protection of Corticospinal Neurons after Spinal Cord Injury

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009cited by this paper
• Regeneration of the ischemic brain by engineered stem cells: fuelling endogenous repair processes.

  2009cited by this paper
• Intravenous Grafts Recapitulate the Neurorestoration Afforded by Intracerebrally Delivered Multipotent Adult Progenitor Cells in Neonatal Hypoxic-Ischemic Rats

  2008cited by this paper
• Transplantation of neural stem cells modified by human neurotrophin-3 promotes functional recovery after transient focal cerebral ischemia in rats.

  2008cited by this paper
• Low Endogenous G-Protein-Coupled Receptor Kinase 2 Sensitizes the Immature Brain to Hypoxia–Ischemia-Induced Gray and White Matter Damage

  2008cited by this paper
• Nerve growth factor promotes survival of new neurons in the adult hippocampus.

  2007cited by this paper
• Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts

  2007cited by this paper
• Behavioral and Histological Characterization of Intrahippocampal Grafts of Human Bone Marrow-Derived Multipotent Progenitor Cells in Neonatal Rats with Hypoxic-Ischemic Injury

  2006cited by this paper
• Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial.

  2005cited by this paper
• Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.

  2005cited by this paper
• A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats.

  2004cited by this paper
• Neonatal brain injury.

  2004cited by this paper
• Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat

  2003cited by this paper
• Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery

  2002cited by this paper
• Whole-body hypothermia for neonatal encephalopathy: animal observations as a basis for a randomized, controlled pilot study in term infants.

  2002cited by this paper
• Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats.

  2001cited by this paper
• Intracisternal antisense oligonucleotide to growth associated protein-43 blocks the recovery-promoting effects of basic fibroblast growth factor after focal stroke.

  1999cited by this paper
• Intraventricular Brain-Derived Neurotrophic Factor Reduces Infarct Size after Focal Cerebral Ischemia in Rats

  1997cited by this paper

• Combined treatment with mesenchymal stem cells and therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy: a phase 1/2 randomized trial

  2025cites this paper
• Intranasal Wharton's Jelly‐Derived Mesenchymal Stem Cell Therapy, Alone or in Conjunction With Therapeutic Hypothermia, Alleviates Neonatal Hypoxic‐Ischemic Brain Injury in Mice

  2025cites this paper
• Hypoxic-Ischemic Encephalopathy in Neonates: Current Concepts in Diagnosis and Management

  2024cites this paper
• Neural Stem Cell Therapy for Alzheimer’s Disease: A-State-of-the-Art Review

  2024cites this paper
• CXCL10 is a crucial chemoattractant for efficient intranasal delivery of mesenchymal stem cells to the neonatal hypoxic-ischemic brain

  2024cites this paper
• Intranasal therapies for neonatal hypoxic-ischemic encephalopathy: Systematic review, synthesis, and implications for global accessibility to care

  2024cites this paper
• Safety and efficacy outcomes after intranasal administration of neural stem cells in cerebral palsy: a randomized phase 1/2 controlled trial

  2023cites this paper
• The Effects of Intranasal Implantation of Mesenchymal Stem Cells on Nitric Monoxide Levels in the Hippocampus, Control of Cognitive Functions, and Motor Activity in a Model of Cerebral Ischemia in Rats

  2023cites this paper
• The fate and prospects of stem cell therapy in the treatment of hypoxic–ischemic encephalopathy

  2023influential citation
• The Upper Nasal Space: Option for Systemic Drug Delivery, Mucosal Vaccines and “Nose-to-Brain”

  2023cites this paper
• Mesenchymal stem cells: a trojan horse to treat glioblastoma

  2023cites this paper
• Progress in the treatment of neonatal hypoxic-ischemic encephalopathy with umbilical cord blood mononuclear cells.

  2023cites this paper
• State of the Art and Future of Stem Cell Therapy in Ischemic Stroke: Why Don’t We Focus on Their Administration?

  2023cites this paper
• Intranasally applied human olfactory mucosa neural progenitor cells migrate to damaged brain regions

  2022cites this paper
• Optimization of an Intranasal Route for the Delivery of Human Neural Stem Cells to Treat a Neonatal Hypoxic-Ischemic Brain Injury Rat Model

  2022cites this paper
• Therapeutic potential of hair follicle-derived stem cell intranasal transplantation in a rat model of ischemic stroke

  2022cites this paper
• Mesenchymal stem cell therapy in perinatal arterial ischemic stroke: systematic review of preclinical studies

  2022cites this paper
• Glial Response to Intranasal Mesenchymal Stem Cells in Intermittent Cuprizone Model of Demyelination

  2022cites this paper
• The therapeutic prospects and challenges of human neural stem cells for the treatment of Alzheimer's Disease

  2022cites this paper
• New idea to promote the clinical applications of stem cells or their extracellular vesicles in central nervous system disorders: Combining with intranasal delivery

  2022cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Intranasal application of stem cells and their derivatives as a new hope in the treatment of cerebral hypoxia/ischemia: a review

  2022cites this paper
• Editing a gateway for cell therapy across the blood–brain barrier

  2022cites this paper
• Stem-cell therapy in neonates – an option?

  2022cites this paper
• Recent Investigations on Neurotransmitters’ Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies—Glia Dynamics in Stem Cell Therapy

  2022cites this paper
• Potential therapeutic applications of stem cell therapy for neonatal hypoxic-ischaemic brain injury

  2022cites this paper
• Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study.

  2022cites this paper
• Therapies for neonatal encephalopathy: Targeting the latent, secondary and tertiary phases of evolving brain injury.

  2021cites this paper
• Drug delivery via the upper nasal space: A novel route for anesthesiologists, intensivists and emergency department physicians?

  2021cites this paper
• Delivery of synthetic mRNAs for tissue regeneration.

  2021cites this paper
• Diagnostic and Therapeutic Potential of Extracellular Vesicles

  2021cites this paper
• Applications of direct nose-to-brain drug delivery in biomedicine, biotechnology, tissue engineering, and immunology

  2021cites this paper
• Nose-to-brain delivery of biologics and stem cells

  2021cites this paper
• Delayed Double Treatment with Adult-Sourced Adipose-Derived Mesenchymal Stem Cells Increases Striatal Medium-Spiny Neuronal Number, Decreases Striatal Microglial Number, and Has No Subventricular Proliferative Effect, after Acute Neonatal Hypoxia-Ischemia in Male Rats

  2021cites this paper
• Transnasal transplantation of human induced pluripotent stem cell‐derived microglia to the brain of immunocompetent mice

  2021cites this paper
• Mesenchymal Stem Cell (MSC)–Derived Extracellular Vesicles Protect from Neonatal Stroke by Interacting with Microglial Cells

  2021cites this paper
• Breast milk stem cells: Are they magic bullets in neonatology?

  2021cites this paper
• MESENCHYMAL STEM CELLS IN THE COMPLEX TREATMENT OF TRAUMATIC BRAIN INJURY

  2021cites this paper
• Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies

  2021influential citation
• Advances in intranasal application of stem cells in the treatment of central nervous system diseases

  2021cites this paper
• Therapeutic potential of stem cells for preterm infant brain damage: can we move from the heterogeneity of preclinical and clinical studies to established therapeutics?

  2021cites this paper
• Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease

  2021cites this paper
• Intranasal drug delivery: opportunities and toxicologic challenges during drug development

  2021cites this paper
• Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.

  2020cites this paper
• Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key

  2020cites this paper
• Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia

  2020cites this paper
• Neuroprotection offered by mesenchymal stem cells in perinatal brain injury: Role of mitochondria, inflammation, and reactive oxygen species

  2020cites this paper
• The Upper Nasal Space—A Novel Delivery Route Ideal for Central Nervous System Drugs

  2020cites this paper
• Review Imaging of intranasal drug delivery to the brain

  2020cites this paper
• Imaging of intranasal drug delivery to the brain.

  2020cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Intranasal administration of Cytoglobin modifies human umbilical cord-derived mesenchymal stem cells and improves hypoxic-ischemia brain damage in neonatal rats by modulating p38 MAPK signaling-mediated apoptosis

  2020cites this paper
• Novel approaches for the delivery of therapeutics in ischemic stroke.

  2020cites this paper
• TARGETABLE MULTI-DRUG NANOPARTICLES FOR TREATMENT OF GLIOBLASTOMA WITH NEUROIMAGING ASSESSMENT

  2020cites this paper
• Intranasal mesenchymal stem cell therapy to boost myelination after encephalopathy of prematurity

  2020cites this paper
• Enhanced Mesenchymal Stromal Cells or Erythropoietin Provide Long-Term Functional Benefit After Neonatal Stroke

  2020cites this paper
• Severe Perinatal Hypoxic-Ischemic Brain Injury Induces Long-Term Sensorimotor Deficits, Anxiety-Like Behaviors and Cognitive Impairment in a Sex-, Age- and Task-Selective Manner in C57BL/6 Mice but Can Be Modulated by Neonatal Handling

  2019cites this paper
• Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine

  2019cites this paper
• The Potential of Stem Cell Therapy to Repair White Matter Injury in Preterm Infants: Lessons Learned From Experimental Models

  2019cites this paper
• Mesenchymal stem cells‐derived IL‐6 activates AMPK/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic‐ischemic brain damage

  2019cites this paper
• Mesenchymal stem cell therapies in brain disease.

  2019cites this paper
• Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges

  2019cites this paper
• Intranasal Stem Cell Treatment as a Novel Therapy for Subarachnoid Hemorrhage

  2018cites this paper
• Intranasal delivery of stem cell-based therapies for the treatment of brain malignancies

  2018cites this paper
• The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System

  2018cites this paper
• The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant

  2018cites this paper
• From cord to caudate: characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain

  2018cites this paper
• Other Tissues-Derived Mesenchymal Stem Cells for Perinatal Brain Injury

  2018cites this paper
• Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice

  2018cites this paper
• Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells

  2018cites this paper
• Migratory potential of transplanted glial progenitors as critical factor for successful translation of glia replacement therapy: The gap between mice and men

  2018cites this paper
• Delayed and repeated intranasal delivery of bone marrow stromal cells increases regeneration and functional recovery after ischemic stroke in mice

  2018cites this paper
• Mechanism of intranasal drug delivery directly to the brain

  2018cites this paper
• Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling

  2018cites this paper
• The neurorestorative effect of human amniotic fluid stem cells on the chronic phase of neonatal hypoxic–ischemic encephalopathy in mice

  2018influential citation
• Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat

  2018cites this paper
• Evaluation of intranasal delivery route of drug administration for brain targeting.

  2018cites this paper
• Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice

  2018cites this paper
• Enhanced Homing Technique of Mesenchymal Stem Cells Using Iron Oxide Nanoparticles by Magnetic Attraction in Olfactory-Injured Mouse Models

  2018cites this paper
• Mesenchymal Stem Cells Form 3D Clusters Following Intraventricular Transplantation

  2018cites this paper
• Dedifferentiated Fat Cells as a Novel Source for Cell Therapy to Target Neonatal Hypoxic-Ischemic Encephalopathy

  2017cites this paper
• Wharton's Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate

  2017cites this paper
• Mesenchymal stem cells attenuate MRI‐identifiable injury, protect white matter, and improve long‐term functional outcomes after neonatal focal stroke in rats

  2017cites this paper
• Neurological consequences of systemic inflammation in the premature neonate

  2017cites this paper
• Genetic and perinatal risk factors for movement disorders

  2017cites this paper
• Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?

  2017cites this paper
• Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy.

  2017cites this paper
• 168 – Pathophysiology of Hypoxic-Ischemic Brain Injury

  2017cites this paper
• Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α‐Synuclein in Parkinsonian Models

  2017cites this paper
• Mesenchymal Stromal Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy

  2017cites this paper
• Excitotoxic injury mechanisms in central white matter

  2017cites this paper
• 6 – Stem Cell Biology

  2017cites this paper
• Review and Outlook of Stem Cell Transplantation for Neonatal Hypoxic- Ischemic Encephalopathy

  2017cites this paper
• Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma.

  2016cites this paper
• Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges.

  2016cites this paper
• Endometrial stem cells expansion capability for local and systemic routes of administration in a model of experimentally injured endometrium

  2016cites this paper
• A Modified Approach to Inducing Bone Marrow Stromal Cells to Differentiate into Cells with Mature Schwann Cell Phenotypes

  2016cites this paper
• Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.

  2016cites this paper
• Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma

  2016cites this paper
• Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G

  2016cites this paper